Literature DB >> 14885407

Pulmonary fibrosis secondary to pneumonia.

S H AUERBACH, O M MIMS, E W GOODPASTURE.   

Abstract

Entities:  

Keywords:  PNEUMONIA/complications; PULMONARY FIBROSIS

Mesh：

Year:  1952        PMID： 14885407      PMCID： PMC1937288     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN： 0002-9440            Impact factor:   4.307


× No keyword cloud information.
  1 in total

1.  Pulmonary changes in uremia.

Authors:  H E BASS; E SINGER
Journal:  J Am Med Assoc       Date:  1950-11-04
  1 in total
  7 in total

Review 1.  Organising pneumonia.

Authors:  J F Cordier
Journal:  Thorax       Date:  2000-04       Impact factor: 9.139

Review 2.  Legionellosis.

Authors:  J A Blackmon; F W Chandler; W B Cherry; A C England; J C Feeley; M D Hicklin; R M McKinney; H W Wilkinson
Journal:  Am J Pathol       Date:  1981-06       Impact factor: 4.307

3.  [Manifestations of pneumonia].

Authors:  H Seidel
Journal:  Beitr Klin Erforsch Tuberk Lungenkr       Date:  1965

Review 4.  Type 2 immunity in tissue repair and fibrosis.

Authors:  Richard L Gieseck; Mark S Wilson; Thomas A Wynn
Journal:  Nat Rev Immunol       Date:  2017-08-30       Impact factor: 53.106

5.  Intraluminal fibrosis in interstitial lung disorders.

Authors:  F Basset; V J Ferrans; P Soler; T Takemura; Y Fukuda; R G Crystal
Journal:  Am J Pathol       Date:  1986-03       Impact factor: 4.307

6.  Krebs Von den Lungen-6 as a predictive indicator for the risk of secondary pulmonary fibrosis and its reversibility in COVID-19 patients.

Authors:  Mingshan Xue; Teng Zhang; Hao Chen; Yifeng Zeng; Runpei Lin; Yingjie Zhen; Ning Li; Zhifeng Huang; Haisheng Hu; Luqian Zhou; Hui Wang; Xiaohua Douglas Zhang; Baoqing Sun
Journal:  Int J Biol Sci       Date:  2021-04-10       Impact factor: 6.580

7.  Risk factors for interstitial lung disease: a 9-year Nationwide population-based study.

Authors:  Won-Il Choi; Sonila Dauti; Hyun Jung Kim; Sun Hyo Park; Jae Seok Park; Choong Won Lee
Journal:  BMC Pulm Med       Date:  2018-06-04       Impact factor: 3.317
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.